Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin.
about
Mitochondrionopathy phenotype in doxorubicin-treated Wistar rats depends on treatment protocol and is cardiac-specificEnhanced Therapeutic Efficacy in Cancer Patients by Short-term Fasting: The Autophagy ConnectionMitophagy and heart failurePotential biomarkers in mouse myocardium of doxorubicin-induced cardiomyopathy: a metabonomic method and its applicationA mouse model for juvenile doxorubicin-induced cardiac dysfunctionCardiomyocyte death in doxorubicin-induced cardiotoxicityEffects of doxorubicin on cardiac muscle subsarcolemmal and intermyofibrillar mitochondria.Time course of changes in oxidative stress and stress-induced proteins in cardiomyocytes exposed to doxorubicin and prevention by vitamin C.P53 inhibition exacerbates late-stage anthracycline cardiotoxicity.Astragalus polysaccharide suppresses doxorubicin-induced cardiotoxicity by regulating the PI3k/Akt and p38MAPK pathways.Clinical significance of ischemia-modified albumin in the diagnosis of doxorubicin-induced myocardial injury in breast cancer patients.Pretreatment with angiotensin-converting enzyme inhibitor improves doxorubicin-induced cardiomyopathy via preservation of mitochondrial function.β2-adrenergic receptors mediate cardioprotection through crosstalk with mitochondrial cell death pathways.Apoptosis in Anthracycline CardiomyopathyAnalysis of proteome changes in doxorubicin-treated adult rat cardiomyocyte.Sirtuin-4 modulates sensitivity to induction of the mitochondrial permeability transition pore.Impaired mitochondrial function is abrogated by dexrazoxane in doxorubicin-treated childhood acute lymphoblastic leukemia survivors.Doxorubicin induced heart failure: Phenotype and molecular mechanisms.Heme oxygenase-1 regulates cardiac mitochondrial biogenesis via Nrf2-mediated transcriptional control of nuclear respiratory factor-1The role of nitric oxide in Doxorubicin-induced cardiotoxicity: experimental study.Enhanced oxidative capacity of ground squirrel brain mitochondria during hibernation.The CO/HO system reverses inhibition of mitochondrial biogenesis and prevents murine doxorubicin cardiomyopathy.Pharmacological modulation of blood-brain barrier increases permeability of doxorubicin into the rat brain.RGS Proteins in Heart: Brakes on the Vagus.Acute doxorubicin cardiotoxicity is associated with p53-induced inhibition of the mammalian target of rapamycin pathway.Metformin rescues the myocardium from doxorubicin-induced energy starvation and mitochondrial damage in rats.Mitochondria death/survival signaling pathways in cardiotoxicity induced by anthracyclines and anticancer-targeted therapies.Creatine kinase-overexpression improves myocardial energetics, contractile dysfunction and survival in murine doxorubicin cardiotoxicity.Mrp1 localization and function in cardiac mitochondria after doxorubicin.Highly potent visnagin derivatives inhibit Cyp1 and prevent doxorubicin cardiotoxicity.Cardiotoxicity of Anticancer Therapeutics.
P2860
Q27301261-4EE6204A-878E-4EA2-8245-B982FF2B7173Q28077408-8C0E4568-3B47-4848-9D7A-1D6802A10728Q28388167-2984F471-A42C-4517-B165-7AD70FA6D0BCQ28478019-38BD2349-CD4F-4A87-A8CF-00F0F91A1505Q33572418-F32CB8D6-129F-4E8C-B984-EF765012A7DEQ33604134-702A10D0-34A5-4F95-89C1-90DD377A891AQ33649513-9452C7FB-9363-44D6-AF1B-4ED76081D940Q33873796-E4C994D6-7568-4C90-9806-EDF07189E60BQ34048273-4AC6EBF6-35FA-4549-B431-8FE5E29D28E5Q34438288-B49B505E-FC8C-4D06-803C-C8C6285DD1FDQ35041318-80529A5D-D366-4805-A000-CA09B5887639Q35214168-1B345F08-96B5-46CC-B755-3F6DAD321B20Q35250102-EF896947-5423-45C6-892B-F2F1AF896ADBQ35642302-C55A84CB-0C06-4470-BCFA-A6BBC4D78831Q35816653-CD0AEE2A-DB29-4021-809F-8D2CEDD9867DQ36401146-B1E15751-57A7-43DE-BE99-79F7C647DCBCQ36649653-B1971C85-C36A-4354-8BC8-CE511BC31036Q36912561-98DCAFC4-BFA2-4232-95B1-A5382BA82ED7Q37223922-D31AD588-3E3B-44D5-9148-0274B678F0A1Q38914599-A00C88DF-88B3-45C4-A80F-6BB8EC50D720Q39026331-34A793E9-A504-4C58-8203-B321A7DBC7F3Q40245145-A3321E51-BF1C-4648-BC78-15A566A0ECC1Q41853014-454468D5-32B6-4053-A39F-6CD1FF283691Q41875965-C5C861DC-580B-4D42-9312-125E63EEB442Q41884318-7007FD51-2A3B-47B2-87BB-D40C8396CD25Q42153380-55048BCB-BDCF-4BE2-BA9F-8A3A535E7A24Q42559258-722617D9-D266-406E-A8AB-315ED308F0E3Q42961337-B67CD7A3-DF2E-4B43-B346-9635D2E1538FQ43141751-F9528E70-10EC-4309-9EEB-EF70735C3C38Q50101800-3FB4674F-4353-4015-8CF4-ADC2BEA64EE8Q50326869-7DE40F11-7277-4E99-9BDC-4D1B4572A3A7
P2860
Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin.
@ast
Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin.
@en
type
label
Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin.
@ast
Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin.
@en
prefLabel
Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin.
@ast
Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin.
@en
P2093
P1433
P1476
Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin.
@en
P2093
P304
P407
P577
2001-01-01T00:00:00Z